AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23537391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 20820870 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I tumors (25%) with EGFR amplification
Number of subjects: 60
Study 20820870 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II tumors (21.7%)
Number of subjects: 60
Study 20820870 — intervention group
Group type: EXPERIMENTAL
Intervention: Type III tumors (11.7%)
Number of subjects: 60
Study 20820870 — intervention group
Group type: EXPERIMENTAL
Intervention: Type IV tumors (41.7%)
Number of subjects: 60
Study 20820870 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic type
Number of subjects: 60
Study 19167667 — intervention group
Group type: EXPERIMENTAL
Intervention: Program X intervention (pedometers and e-mail support)
Number of subjects: 124
Study 16704382 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 live cases (n=32)
Number of subjects: 55
Study 16704382 — intervention group
Group type: COMPARATOR
Intervention: 2 live and 2 virtual cases (n=23)
Number of subjects: 55
Study 15546306 — intervention group
Group type: EXPERIMENTAL
Intervention: Active biventricular pacing (CRT)
Number of subjects: 110
Study 11766094 — intervention group
Group type: EXPERIMENTAL
Intervention: Button‐bracket splint (BS)
Number of subjects: 10
Study 11766094 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin splint (RS)
Number of subjects: 10
Study 11766094 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium Trauma Splint (TTS)
Number of subjects: 10
Study 11766094 — intervention group
Group type: EXPERIMENTAL
Intervention: Wire‐composite splint (WCS)
Number of subjects: 10
Study 9246043 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alone 3 MU three times a week
Number of subjects: 108
Study 9246043 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN 3 MU three times a week + UDCA 250 mg twice a day
Number of subjects: 108
Study 9246043 — intervention group
Group type: COMPARATOR
Intervention: UDCA alone 250 mg twice a day
Number of subjects: 108
Study 8471127 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright visor (6000 lux) for 30 or 60 minutes in the morning for 1 week
Number of subjects: 55
Study 8471127 — intervention group
Group type: COMPARATOR
Intervention: Dim visor (400 lux) for 30 or 60 minutes in the morning for 1 week
Number of subjects: 55
Study 3326393 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg oral PGE2 given hourly for two 12-h periods
Number of subjects: 191
Study 3326393 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PGE2 priming and induction of labor with oxytocin
Number of subjects: 191
Study 3326393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study 29898851 — intervention group
Group type: EXPERIMENTAL
Intervention: Video information (three-dimensional educational video)
Number of subjects: 821
Study 29898851 — intervention group
Group type: COMPARATOR
Intervention: Standard information
Number of subjects: 821
Study 27631254 — intervention group
Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CAP group)
Number of subjects: 183
Study 27631254 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy (non-CAP group)
Number of subjects: 183
Study 24638843 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 3746
Study 24638843 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 3746
Study 22317756 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (25 μg/d as cholecalciferol)
Number of subjects: 77
Study 22317756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 20075050 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and post-bronchodilator spirometry or a single bronchial challenge test
Number of subjects: 540
Study 20075050 — intervention group
Group type: COMPARATOR
Intervention: Tapering of asthma medications and repeated bronchial challenge tests
Number of subjects: 540
Study 18591761 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Kinesio Tape (KT)
Number of subjects: 42
Study 18591761 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesio Tape
Number of subjects: 42
Study 15573239 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidectomy
Number of subjects: 95
Study 15573239 — intervention group
Group type: COMPARATOR
Intervention: Open hemorrhoidectomy using Ligasure
Number of subjects: 95
Study 11333516 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (OLZ)
Number of subjects: 100
Study 11333516 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (HAL)
Number of subjects: 100
Study 11333516 — intervention group
Group type: COMPARATOR
Intervention: Risperidone (RIS)
Number of subjects: 100
Study 9613362 — intervention group
Group type: EXPERIMENTAL
Intervention: Stadiometer (H)
Number of subjects: 32
Study 9613362 — intervention group
Group type: COMPARATOR
Intervention: Gulliver (G)
Number of subjects: 32
Study 9613362 — intervention group
Group type: COMPARATOR
Intervention: Book and tape method (TM)
Number of subjects: 32
Study 9613362 — intervention group
Group type: COMPARATOR
Intervention: Gulliver (G) and Book/Tape Method (TM)
Number of subjects: 32
Study 7992933 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (1 g intravenous injection immediately after induction of anaesthesia, followed by postoperative injections every 6 hours for 36 hours, total of 6 injections)
Number of subjects: 256
Study 7992933 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole (1.5 g intravenous injection immediately after induction of anaesthesia, followed by postoperative injections every 6 hours for 36 hours, total of 6 injections)
Number of subjects: 256
Study 2736886 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-holding for 6 seconds
Number of subjects: 39
Study 2736886 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-holding for 10 seconds
Number of subjects: 39
Study 2736886 — intervention group
Group type: EXPERIMENTAL
Intervention: Qc in patients
Number of subjects: 39
Study 2736886 — intervention group
Group type: EXPERIMENTAL
Intervention: Qc in normal subjects
Number of subjects: 39
Study 2736886 — intervention group
Group type: EXPERIMENTAL
Intervention: Qf
Number of subjects: 39
Study 29206596 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Aided Detection (CAD) system
Number of subjects: 100
Study 29206596 — intervention group
Group type: COMPARATOR
Intervention: No Computer-Aided Detection (CAD) system
Number of subjects: 100
Study 26707087 — intervention group
Group type: EXPERIMENTAL
Intervention: .20 mg/kg esketamine
Number of subjects: 30
Study 26707087 — intervention group
Group type: EXPERIMENTAL
Intervention: .40 mg/kg esketamine
Number of subjects: 30
Study 26707087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 24883300 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.30 mg/kg rectal midazolam diluted with 5 mL saline (Group M)
Number of subjects: 40
Study 24883300 — intervention group
Group type: COMPARATOR
Intervention: 5 mL saline (Group C)
Number of subjects: 40
Study 22467361 — intervention group
Group type: EXPERIMENTAL
Intervention: Resource-oriented cognitive-behavioral therapy (ROCBT)
Number of subjects: 51
Study 22467361 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 51
Study 22467361 — intervention group
Group type: EXPERIMENTAL
Intervention: ROCBT and CT
Number of subjects: 51
Study 20554904 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sea buckthorn (SB) oil, 2 g daily for 3 months
Number of subjects: 100
Study 20554904 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil, 2 g daily for 3 months
Number of subjects: 100
Study 20554904 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sea buckthorn (SB) oil
Number of subjects: 100
Study 18414195 — intervention group
Group type: EXPERIMENTAL
Intervention: Written invitation letter
Number of subjects: 43523
Study 18414195 — intervention group
Group type: COMPARATOR
Intervention: Control group (no invitation letter)
Number of subjects: 43523
Study 15750155 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic injection (90 and 50 mL at 3 and 1.5 mL/s) of intravenous contrast (300 mg/mL iodine)
Number of subjects: 40
Study 15750155 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-phase injection (90, 40, and 40 mL at 3, 2, and 1.5 mL/s)
Number of subjects: 40
Study 15750155 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-phase injection (80 and 60 mL at 3 and 1.5 mL/s) in the caudocranial direction with a 50-s delay
Number of subjects: 40
Study 15750155 — intervention group
Group type: COMPARATOR
Intervention: No intravenous contrast agent
Number of subjects: 40
Study 11919643 — intervention group
Group type: EXPERIMENTAL
Intervention: Summer's Eve (SE) vaginal moisturizer based on pectin
Number of subjects: 51
Study 11919643 — intervention group
Group type: COMPARATOR
Intervention: Replens (Rp) vaginal moisturizer based on polycarbophil
Number of subjects: 51
Study 11919643 — intervention group
Group type: EXPERIMENTAL
Intervention: Summer's Eve (SE) vaginal moisturizer
Number of subjects: 51
Study 11919643 — intervention group
Group type: COMPARATOR
Intervention: Replens (Rp) vaginal moisturizer
Number of subjects: 51
Study 10989865 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 5 mg iv
Number of subjects: 60
Study 10989865 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 50 microg iv
Number of subjects: 60
Study 10989865 — intervention group
Group type: COMPARATOR
Intervention: Saline 2 ml iv
Number of subjects: 60
Study 8822682 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular gentamicin
Number of subjects: 142
Study 8822682 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics
Number of subjects: 142
Study 1424430 — intervention group
Group type: EXPERIMENTAL
Intervention: d-methylphenidate
Number of subjects: 9
Study 1424430 — intervention group
Group type: EXPERIMENTAL
Intervention: l-methylphenidate
Number of subjects: 9
Study 1424430 — intervention group
Group type: EXPERIMENTAL
Intervention: dl-methylphenidate
Number of subjects: 9
Study 1424430 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study 3906218 — intervention group
Group type: EXPERIMENTAL
Intervention: RFP plus INH for 9 months (R9 group)
Number of subjects: 151
Study 3906218 — intervention group
Group type: COMPARATOR
Intervention: RFP plus INH for 12 months (R12 group)
Number of subjects: 151
Study 3906218 — intervention group
Group type: EXPERIMENTAL
Intervention: R9 group
Number of subjects: 151
Study 3906218 — intervention group
Group type: COMPARATOR
Intervention: R12 group
Number of subjects: 151
Study 3906218 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 151
Study 3906218 — intervention group
Group type: COMPARATOR
Intervention: Complicated case with diabetes mellitus in R12 group
Number of subjects: 151
Study 31096485 — intervention group
Group type: EXPERIMENTAL
Intervention: Template matching
Number of subjects: 240
Study 31096485 — intervention group
Group type: COMPARATOR
Intervention: Regression model
Number of subjects: 240
Study 29683690 — intervention group
Group type: EXPERIMENTAL
Intervention: Scarcity and authority manipulation in Experiment 1
Number of subjects: 502
Study 29683690 — intervention group
Group type: EXPERIMENTAL
Intervention: Low, medium, or high activation fee in Experiment 2
Number of subjects: 502
Study 26228264 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking intervention (n=11)
Number of subjects: 33
Study 26228264 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=22)
Number of subjects: 33
Study 26228264 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study 23384155 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative version of the video decision aid (includes stories from breast cancer survivors)
Number of subjects: 200
Study 23384155 — intervention group
Group type: COMPARATOR
Intervention: Control version of the video decision aid (no patient stories)
Number of subjects: 200
Study 23384155 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative version of the video decision aid
Number of subjects: 200
Study 23384155 — intervention group
Group type: COMPARATOR
Intervention: Control version of the video decision aid
Number of subjects: 200
Study 22726401 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 876
Study 22726401 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 876
Study 22726401 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker titration
Number of subjects: 876
Study 20087086 — intervention group
Group type: EXPERIMENTAL
Intervention: TZP-101 (80 microg/kg)
Number of subjects: 236
Study 20087086 — intervention group
Group type: EXPERIMENTAL
Intervention: TZP-101 (480 microg/kg)
Number of subjects: 236
Study 20087086 — intervention group
Group type: EXPERIMENTAL
Intervention: TZP-101
Number of subjects: 236
Study 20087086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 16856128 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 83
Study 15703894 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 597
Study 15703894 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control formula
Number of subjects: 597
Study 11696811 — intervention group
Group type: EXPERIMENTAL
Intervention: Alarm therapy combined with 40 microg intranasal desmopressin for 3 weeks followed by 20 microg desmopressin for 3 weeks (group 1)
Number of subjects: 93
Study 11696811 — intervention group
Group type: COMPARATOR
Intervention: Alarm therapy and placebo (group 2)
Number of subjects: 93
Study 11696811 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment modalities (group 1 and group 2)
Number of subjects: 93
Study 9216706 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic therapy plus radiotherapy (Arm B)
Number of subjects: 37
Study 9216706 — intervention group
Group type: COMPARATOR
Intervention: Systemic therapy alone (Arm A)
Number of subjects: 37
Study 9216706 — intervention group
Group type: EXPERIMENTAL
Intervention: T-status at diagnosis
Number of subjects: 37
Study 9216706 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-free interval from diagnosis to recurrence
Number of subjects: 37
Study 7970071 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemiluminescence molecular hybridization
Number of subjects: 0
Study 7970071 — intervention group
Group type: COMPARATOR
Intervention: Traditional examinations (colposcopy, cytology, histology)
Number of subjects: 0
Study 3301454 — intervention group
Group type: EXPERIMENTAL
Intervention: Dothiepin
Number of subjects: 0
Study 3301454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2213264 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocolysis and prophylactic antibiotic administration
Number of subjects: 112
Study 2213264 — intervention group
Group type: COMPARATOR
Intervention: Passive expectant management (control)
Number of subjects: 112
Study 2213264 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftizoxime
Number of subjects: 112
Study 2213264 — intervention group
Group type: EXPERIMENTAL
Intervention: Other antibiotics (cefoxitin, cefazolin, ampicillin)
Number of subjects: 112
Study 4320676 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiil dialyser
Number of subjects: 24
Study 4320676 — intervention group
Group type: COMPARATOR
Intervention: Coil dialyser
Number of subjects: 24
Study 4320676 — intervention group
Group type: EXPERIMENTAL
Intervention: Home dialysis with Kiil dialyser
Number of subjects: 24
Study 4320676 — intervention group
Group type: COMPARATOR
Intervention: Home dialysis with coil dialyser
Number of subjects: 24
Study 30149148 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF + plerixafor
Number of subjects: 20
Study 30149148 — intervention group
Group type: COMPARATOR
Intervention: G‐CSF alone
Number of subjects: 20
Study 28777665 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-row repair with sutures
Number of subjects: 24
Study 28777665 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-row repair with labral tape
Number of subjects: 24
Study 28777665 — intervention group
Group type: COMPARATOR
Intervention: Single-row repair with simple sutures
Number of subjects: 24
Study 28777665 — intervention group
Group type: COMPARATOR
Intervention: Single-row repair with horizontal mattress sutures
Number of subjects: 24
Study 28777665 — intervention group
Group type: COMPARATOR
Intervention: Single-row vs Double-row techniques
Number of subjects: 24
Study 28777665 — intervention group
Group type: COMPARATOR
Intervention: Simple suture vs Horizontal mattress suture
Number of subjects: 24
Study 28777665 — intervention group
Group type: COMPARATOR
Intervention: Double-row techniques with sutures vs labral tape
Number of subjects: 24
Study 26324857 — intervention group
Group type: EXPERIMENTAL
Intervention: High (therapeutic) stimulation
Number of subjects: 12
Study 26324857 — intervention group
Group type: COMPARATOR
Intervention: Low (subtherapeutic) stimulation
Number of subjects: 12
Study 23230898 — intervention group
Group type: EXPERIMENTAL
Intervention: NODAT within 1 year
Number of subjects: 118
Study 23230898 — intervention group
Group type: EXPERIMENTAL
Intervention: Recipient age (per year)
Number of subjects: 118
Study 23230898 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (at 3 months)
Number of subjects: 118
Study 23230898 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (at 3 months)
Number of subjects: 118
Study 23230898 — intervention group
Group type: EXPERIMENTAL
Intervention: All-cause mortality in NODAT recipients
Number of subjects: 118
Study 23230898 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (HR 1.075, CI 1.042-1.110)
Number of subjects: 118
Study 23230898 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year creatinine (HR 1.007, CI 1.004-1.010)
Number of subjects: 118
Study 23230898 — intervention group
Group type: EXPERIMENTAL
Intervention: NODAT within 3 months (HR 2.4, CI 1.2-4.9)
Number of subjects: 118
Study 21641196 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutter(®)VRP1
Number of subjects: 18
Study 21641196 — intervention group
Group type: COMPARATOR
Intervention: PEP
Number of subjects: 18
Study 19262975 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (EG) - supervised high-impact exercises three times per week for 12 months.
Number of subjects: 120
Study 19262975 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no exercise intervention.
Number of subjects: 120
Study 16442893 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with cardiac tamponade
Number of subjects: 102060
Study 16442893 — intervention group
Group type: COMPARATOR
Intervention: Patients without cardiac tamponade
Number of subjects: 102060
Study 15017898 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant chemo‐radiotherapy
Number of subjects: 80
Study 15017898 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 80
Study 11343668 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factor case-management program (n = 99)
Number of subjects: 201
Study 11343668 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (n = 102)
Number of subjects: 201
Study 9216955 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (Mel) 5 mg po administered at 1300
Number of subjects: 8
Study 9216955 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural change from upright to supine position at 1000
Number of subjects: 8
Study 7970472 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapartum intrathecal narcotic analgesia (25 micrograms fentanyl and 0.25 mg morphine sulfate)
Number of subjects: 150
Study 7970472 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapartum intrathecal narcotic analgesia
Number of subjects: 150
Study 7970472 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched by gravidity and parity)
Number of subjects: 150
Study 3313684 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy for 6 months
Number of subjects: 0
Study 3313684 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 0
Study 3313684 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy
Number of subjects: 0
Study 29189540 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtenon irrigation of Mitomycin-C
Number of subjects: 100
Study 29189540 — intervention group
Group type: COMPARATOR
Intervention: Subtenon sponge application of Mitomycin-C
Number of subjects: 100
Study 29189540 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy/Ex-PRESS alone
Number of subjects: 100
Study 29189540 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 100
Study 28923050 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN), manual physiotherapy and therapeutic exercise
Number of subjects: 36
Study 28923050 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling, manual physiotherapy and therapeutic exercise
Number of subjects: 36
Study 26352805 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT 5716 at 3×10(9) CFU/day
Number of subjects: 4
Study 26352805 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT 5716 at 6×10(9) CFU/day
Number of subjects: 4
Study 26352805 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT 5716 at 9×10(9) CFU/day
Number of subjects: 4
Study 26352805 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 4
Study 23442315 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 60
Study 23442315 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 60
Study 25426790 — intervention group
Group type: EXPERIMENTAL
Intervention: Edible yogurt containing Lactobacillus rhamnosus L8020
Number of subjects: 50
Study 25426790 — intervention group
Group type: COMPARATOR
Intervention: Placebo yogurt
Number of subjects: 50
Study 19832996 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care (case manager coordinated support and brief psychological treatment, enhanced specialist and GP communication)
Number of subjects: 0
Study 19832996 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 16467233 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary modification intervention (n = 19,541)
Number of subjects: 48835
Study 16467233 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (usual eating pattern, n = 29,294)
Number of subjects: 48835